Comparison of the effect of Metformin and Empagliflozin in treatment of prediabetic patients.

Phase 3

Recruiting

• Conditions: Prediabetes.; Abnormal glucose tolerance test; R73.0

• Registration Number: IRCT20210926052602N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Prediabetic patient
Age between 30-80 years old
BMI>25

Exclusion Criteria

Treatment with hormones or drugs that interference glucose metabolism
GFR< 45
Neurogenic bladder disorder
Pregnant or breast feeding mothers
Allergy to Empagliflozin or Metformin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose. Timepoint: 3 months. Method of measurement: Blood sample.;Blood pressure. Timepoint: 3 months. Method of measurement: Blood pressure monitor.;Weight. Timepoint: 3 months. Method of measurement: Weight scale.